Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    5.00 (5.71%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Board Changes

17 Apr 2024 10:05

RNS Number : 9733K
Crimson Tide PLC
17 April 2024
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time. Upon the publication of this announcement, this inside information is now considered to be in the public domain

 

 

Crimson Tide plc

("Crimson Tide" or "the Company")

 

Board Changes

 

Crimson Tide plc (TIDE), the provider of the mpro5 process management app, is pleased to announce the following Board changes which take effect today.

 

Philip ('Phil') Douglas James Meyers will join the Board as Chief Executive Officer ("CEO"), having joined Crimson Tide's Operating Board in August 2023 as Chief Operating Officer, a role in which he has made an immediate impact. Phil is an accomplished leader in global technology companies, most recently with HiSky Limited (2019 - 2022), a leading developer and provider of satellite Internet of Things (IoT) networks where he held the role of UK CEO. He has previously held the roles of Vice President of Capabilities and Innovation at Inmarsat Global Limited (2014 - 2019), the world leader in global mobile satellite communications, and Channel Sales Manager for BlackBerry Limited (2011 - 2014). Phil has significant experience in launching and improving partner-led growth strategies in the UK and USA. He holds a Master of Business Administration from ENEB Business School.

 

James Richard Joyce will join the Board as an Independent Non-Executive Director. James is a chartered accountant and experienced corporate finance director with significant experience of the AIM market. Since 2005, he has been a corporate finance director at WH Ireland, the broking and corporate advisory firm. James was previously a corporate finance director at Sigma Capital (2000 - 2005). James qualified as an ACA and has formerly held positions at the London Stock Exchange and Arthur Andersen, the global accounting and advisory firm. James will chair the Audit Committee following the completion of this year's audit.

 

Jacqueline Daniell, the Company's current CEO, will remain on the Board and take the newly created role of Non-Executive Deputy Chair, and will focus on assisting the Company's efforts in marketing, growth and Investor Relations.

 

Barrie Whipp, Chairman of Crimson Tide, commented: "Phil has demonstrated the ability to lead the Company into its next period of growth and innovation. More importantly he has gained the trust of the Board and staff and I endorse him wholeheartedly. Jacqui will now be able to use her extensive experience in marketing, growth and Investor Relations to help us with our expansion strategy. I will focus on product innovation and international opportunities. James Joyce has a wealth of Capital Markets knowledge with a real understanding of the requirements of AIM-listed growth companies. I am sure that the Board will be enhanced by these appointments."

 

Regulatory Disclosures:

The following disclosures are made pursuant to AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

 

In addition to his appointment as an Independent Non-Executive Director of Crimson Tide, James Richard Joyce aged 54, does not hold any current directorships and has not held any directorships in the five years preceding his appointment at Crimson Tide plc. James Joyce holds no ordinary shares in the Company.

 

In addition to his appointment as Chief Executive Officer of Crimson Tide, Philip Douglas James Meyers aged 44, does not hold any current directorships and has not held any directorships in the five years preceding his appointment at Crimson Tide plc. Philip Meyers holds no ordinary shares in the Company.

 

Save as set out above, there is no further information to be disclosed under Schedule Two paragraph (g) of the AIM Rules.

 

For further information, please contact:

 

Crimson Tide plc

+44 1892 542444

Barrie Whipp / Jacqueline Daniell

 

Cavendish Capital Markets Limited (Nominated adviser and Broker)

+44 20 7220 0500

Julian Blunt / Dan Hodkinson - Corporate Finance

 

Andrew Burdis - Corporate Broking

 

Alma PR - (Financial PR)

+44 7780 901 979

Josh Royston

 

 

Crimson Tide provides mpro5, the process management app. For further information, see mpro5.com and on Crimson Tide plc, crimsontide.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANLXFEFLEEA
Date   Source Headline
30th Jun 202011:53 amRNSResult of AGM and Trading Update
15th Jun 202010:42 amRNSSignificant Contract Win
9th Jun 20204:06 pmRNSAnnual Report and Notice of AGM
7th May 20207:11 amRNSPreliminary Results
4th May 20204:05 pmRNSDIRECTOR RESIGNATION
1st Apr 20203:30 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSStatement regarding Coronavirus
13th Mar 20207:00 amRNSChange of Adviser
25th Feb 20208:19 amRNSHolding(s) in Company
18th Feb 20207:00 amRNSSignificant contract wins in the rail sector
28th Jan 202010:43 amRNSHolding(s) in Company
3rd Jan 20209:17 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSSignificant long-term contract and trading update
1st Oct 20197:00 amRNSSignificant long-term contract win
27th Sep 20197:00 amRNSInterim Results
1st Jul 20197:00 amRNSDirector and Company Secretary Appointment
28th Jun 20193:02 pmRNSResult of AGM
27th Jun 20197:00 amRNSContract Wins and New Partnerships
7th Jun 20197:00 amRNSFinal Results and Notice of AGM
17th May 20197:00 amRNSHolding(s) in Company
30th Apr 20197:00 amRNSPreliminary Announcement of Results to 31/12/18
16th Apr 20199:20 amRNSHolding(s) in Company
1st Mar 20192:56 pmRNSHolding(s) in Company
7th Feb 20197:00 amRNSContract Wins in the rail sector
29th Jan 20197:00 amRNSTrading Update
2nd Nov 20182:08 pmRNSExercise Of Options
4th Oct 20184:47 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSContract Wins and Recruitment
5th Jul 20188:38 amRNSmpro5 healthcare update
2nd Jul 201811:21 amRNSResult of AGM
7th Jun 20188:28 amRNSFinal Results and Notice of AGM
24th Apr 20187:00 amRNSChange of Adviser
13th Apr 20187:00 amRNSPreliminary Results to 31 December 2017
28th Mar 20187:00 amRNSAppointment of new CEO
27th Feb 20187:00 amRNSTrading Statement
19th Dec 20173:44 pmRNSDirector/PDMR Shareholding
15th Dec 201711:30 amRNSExercise of Options
8th Dec 20173:37 pmRNSResult of GM
23rd Nov 20177:00 amRNSNotice of GM
24th Oct 20177:00 amRNSSeries of contract wins for mpro5
17th Oct 20177:00 amRNSDirectorate Change
7th Sep 20177:00 amRNSInterim Results
11th Jul 20177:00 amRNSSignificant mpro5 Contract Win in the Netherlands
29th Jun 20175:47 pmRNSResult of AGM
6th Jun 20172:00 pmRNSFinal Results and Notice of AGM
30th May 20177:00 amRNSInternational Expansion Update
30th Mar 20177:00 amRNSPreliminary Results
2nd Feb 20177:00 amRNSUpdate on International Expansion
14th Dec 20167:00 amRNSTrading Update and Contract Rollout

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.